158 related articles for article (PubMed ID: 1647350)
1. Comparative effects of procainamide, tocainide and lorcainide on Na(+)-K(+)-ATPase in guinea pig heart preparations.
Dzimiri N; Almotrefi AA
Gen Pharmacol; 1991; 22(2):403-6. PubMed ID: 1647350
[TBL] [Abstract][Full Text] [Related]
2. Influence of lorcainide on microsomal Na+, K(+)-ATPase in guinea-pig isolated heart preparations.
Almotrefi AA; Dzimiri N
Br J Pharmacol; 1991 Feb; 102(2):530-2. PubMed ID: 1849773
[TBL] [Abstract][Full Text] [Related]
3. The effect of modifying potassium concentration on the inhibition of myocardial Na(+)-K(+)-ATPase by two class IB antiarrhythmic drugs: lidocaine and tocainide.
Almotrefi AA; Dzimiri N
Gen Pharmacol; 1991; 22(6):1097-101. PubMed ID: 1667301
[TBL] [Abstract][Full Text] [Related]
4. Variations in potassium concentration modify the inhibitory effect of lorcainide on myocardial Na(+)-K(+)-ATPase activity.
Almotrefi AA; Dzimiri N
Br J Pharmacol; 1991 Dec; 104(4):793-6. PubMed ID: 1667285
[TBL] [Abstract][Full Text] [Related]
5. Class I antiarrhythmic drug effects on ouabain binding to guinea pig cardiac Na+ -K+ ATPase.
Almotrefi AA; Basco C; Moorji A; Dzimiri N
Can J Physiol Pharmacol; 1999 Nov; 77(11):866-70. PubMed ID: 10593659
[TBL] [Abstract][Full Text] [Related]
6. Interaction between potassium concentration and inhibition of myocardial Na(+)-K(+)-ATPase by two class 1A antiarrhythmic drugs: quinidine and procainamide.
Dzimiri N; Almotrefi AA
Arch Int Pharmacodyn Ther; 1991; 314():34-43. PubMed ID: 1668603
[TBL] [Abstract][Full Text] [Related]
7. Effects of class I antiarrhythmic drugs on mitochondrial ATPase activity in guinea pig heart preparations.
Almotrefi AA
Gen Pharmacol; 1993 Jan; 24(1):233-7. PubMed ID: 8482500
[TBL] [Abstract][Full Text] [Related]
8. Effects of quinidine, lidocaine and encainide on guinea pig myocardial Na(+)-K(+)-ATPase activity.
Almotrefi AA; Dzimiri N
Res Commun Chem Pathol Pharmacol; 1990 Aug; 69(2):253-6. PubMed ID: 2168576
[TBL] [Abstract][Full Text] [Related]
9. Effects of beta-adrenergic blockers on Na(+)-K(+)-ATPase activity in guinea-pig heart preparations: comparison with ouabain.
Almotrefi AA; Dzimiri N
Arch Int Pharmacodyn Ther; 1991; 310():94-101. PubMed ID: 1685314
[TBL] [Abstract][Full Text] [Related]
10. Interaction of bretylium tosylate with guinea-pig myocardial Na(+)-K(+)-ATPase.
Dzimiri N; Almotrefi AA
Gen Pharmacol; 1991; 22(5):935-8. PubMed ID: 1662173
[TBL] [Abstract][Full Text] [Related]
11. Effects of procainamide, tocainide and phenytoin on guinea pig cardiac mitochondrial ATPase activity.
Dzimiri N
Res Commun Chem Pathol Pharmacol; 1993 Apr; 80(1):121-4. PubMed ID: 8488338
[TBL] [Abstract][Full Text] [Related]
12. Cardiac electrophysiology of four new antiarrhythmic drugs--encainide, flecainide, lorcainide and tocainide.
Camm AJ
Eur Heart J; 1984 Sep; 5 Suppl B():75-9. PubMed ID: 6437820
[No Abstract] [Full Text] [Related]
13. Blockade of 2,4-dinitrophenol induced ATP sensitive potassium current in guinea pig ventricular myocytes by class I antiarrhythmic drugs.
Wu B; Sato T; Kiyosue T; Arita M
Cardiovasc Res; 1992 Nov; 26(11):1095-101. PubMed ID: 1291087
[TBL] [Abstract][Full Text] [Related]
14. Canine digitalis arrhythmia as a model for detecting Na-channel blocking antiarrhythmic drugs: a comparative study using other canine arrhythmia models and the new antiarrhythmic drugs, propafenone, tocainide, and SUN 1165.
Hashimoto K; Ishii M; Komori S; Mitsuhashi H
Heart Vessels; 1985 Feb; 1(1):29-35. PubMed ID: 2419304
[TBL] [Abstract][Full Text] [Related]
15. Interval-dependent effects of small antiarrhythmic drugs on excitability of guinea-pig myocardium.
Courtney KR
J Mol Cell Cardiol; 1980 Nov; 12(11):1273-86. PubMed ID: 6777501
[No Abstract] [Full Text] [Related]
16. New drugs in the management of ventricular arrhythmias.
Sanna GP
G Ital Cardiol; 1984 Oct; 14(10):788-97. PubMed ID: 6083894
[TBL] [Abstract][Full Text] [Related]
17. Investigation of class I anti-arrhythmic drug actions on guinea-pig cardiac mitochondrial lactate dehydrogenase activity.
Dzimiri N; Almotrefi AA
Clin Exp Pharmacol Physiol; 1993 Apr; 20(4):201-6. PubMed ID: 8485920
[TBL] [Abstract][Full Text] [Related]
18. Effects of BRB-I-28, a novel antiarrhythmic agent, and its derivatives on cardiac Na+,K(+)-ATPase, Mg(2+)-ATPase activities and contractile force.
Chen CL; Sangiah S; Patterson E; Berlin KD; Garrison GL; Dunn W; Nan Y; Scherlag BJ; Lazzara R
Res Commun Chem Pathol Pharmacol; 1992 Oct; 78(1):3-16. PubMed ID: 1334277
[TBL] [Abstract][Full Text] [Related]
19. [Effects of lorcainide, a new antiarrhythmic agent, on experimental cardiac arrhythmias].
Fukuda H; Goto M; Kondo M; Uchigasaki T; Sekino Y
Nihon Yakurigaku Zasshi; 1983 Feb; 81(2):115-26. PubMed ID: 6852683
[TBL] [Abstract][Full Text] [Related]
20. Clinical profiles of newer class I antiarrhythmic agents--tocainide, mexiletine, encainide, flecainide and lorcainide.
Pottage A
Am J Cardiol; 1983 Sep; 52(6):24C-31C. PubMed ID: 6414279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
